Cat. No. 3508
Alternative Name: LG 1506
Chemical Name: (2E,4E,6Z)-7-[2-(2,2-Difluoroethoxy
Biological ActivitySelective RXR modulator (Ki values are 3, 9 and 11 for RXRα, RXRβ and RXRγ respectively). Displays poor binding affinity for RAR isoforms (Ki values are 2746, 3516 and >10,000 nM for RARα, RARβ and RARγ respectively). Binding to RXR results in selective activation of RXR:PPARγ, RXR:PPARα and RXR:PPARδ heterodimers.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Pinaire et al (2007) Therapeutic potential of retinoid X receptor modulators for the treatment of the metabolic syndrome. PPAR Res. 94156. PMID: 17497022.
Leibowitz et al (2006) Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes. Endocrinology 147 1044. PMID: 16269450.
Michellys et al (2003) Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. J.Med.Chem. 46 2683. PMID: 12801232.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for LG 101506 include:
Ronn et al (2015) Retinoic Acid regulates hematopoietic development from human pluripotent stem cells. Development 4 269. PMID: 25680478.
Do you know of a great paper that uses LG 101506 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: LG 101506, supplier, LG101506, retinoid, x, receptors, rxr, modulators, rxra, rxrb, rxrg, rxralpha, rxrbeta, rxrgamma, rxrα, rxrβ, rxrγ, LG1506, LG_1506, Tocris Bioscience, Retinoid X Receptor Modulator products
Find multiple products by catalog number
New Products in this Area
Synthetic retinoid; induces differentiation of stem cellsSI-2 hydrochloride
Steroid receptor coactivator 3 (SRC-3) inhibitorSR 0987
T cell-specific RORγ (RORγt) agonist
April 1 - 5, 2017
Washington, D.C., USA